FDA’s tablet scoring guidance may see provisions removed that would require testing in patients after an advisory committee said patient behavior is too unpredictable to make the approach reliable.
FDA in a 2011 draft guidance wanted manufacturers to test whether their tablet scoring convention allowed patients taking the medicine...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?